Webster Brian Daniel 4
Research Summary
AI-generated summary
Kestra Medical Technologies CEO Brian Webster Sells 15,000 Shares
What Happened
Brian D. Webster, President and Chief Executive Officer of Kestra Medical Technologies (KMTS), sold 15,000 shares in an open-market/ private sale on June 15, 2026. The reported weighted-average sale price was $20.81 per share, producing proceeds of approximately $312,143. This was a sale (S), which is often routine rather than a bullish signal.
Key Details
- Transaction date: 2026-06-15 (reported on Form 4 filed 2026-06-17) — filing appears timely.
- Transaction type/code: Sale (S) — open market or private sale.
- Shares sold: 15,000; weighted-average price: $20.81; total proceeds: ~$312,143.
- Price range: shares were sold at prices between $20.54 and $21.39 (weighted average shown).
- Footnotes: Transaction occurred pursuant to a Rule 10b5-1 trading plan adopted 2025-09-29. The filer notes the weighted average and offers to provide breakdown by price on request.
- Shares owned after transaction: Not disclosed in the information provided.
Context
Sales made under an established 10b5-1 plan are pre-arranged and are commonly used by insiders to sell shares on a scheduled basis; such sales do not necessarily reflect current views on the company's prospects. This report shows a routine insider sale rather than a purchase or exercise.